Successful collaboration delivers results

With different roles and expertise, they work towards the same overall goal – to contribute to Uppsala University’s efforts to take research forward and utilise knowledge in society. Meet Gunilla Lundmark, CEO of UU Invest, and Malin Graffner Nordberg, Head of UU Innovation, as they sum up the past year, talk about the collaboration, and discuss their plans and hopes for 2022.

 

It is almost impossible to keep a description of how UU Innovation and UU Invest work together brief. But the collaboration is crucial, and the roles are clear.

UU Invest, the University’s holding company, is tasked with investing in ideas, projects and companies based on research and knowledge generated at Uppsala University. UU Innovation’s role is to inspire and guide researchers and students forward in their quest to turn their research results and ideas into useful solutions, and to offer practical support in evaluating and developing the viability of the ideas. Wherever there is potential – the two actors sometimes come together in joint projects. And when ideas take off, UU Invest is often the first investor in the companies that are created.

A successful year for UU Innovation

When Malin Graffner Nordberg looks back over 2021, the words fantastic and exciting come to mind as she sums up the year.

“2021 was a fantastic year. Our work has produced positive and exciting results, and we have developed our offerings to both researchers and students and have made new efforts to reach out. Particularly exciting are the new dialogues we have established with research leaders at different departments to discuss both utilisation of research results and reducing the imbalance in the flow of ideas. This dialogue has generated curiosity, expanded our contact network, and increased the flow of ideas during the year,” says Malin.

A focus for Malin and her team has also been on arousing curiosity and lowering the thresholds for support. Something new this year, for example, is a simple self-test that helps researchers identify what they are creating in their research that has the potential to be useful outside their immediate research environment.

Success breeds success

The fact that UU Innovation’s work has been successful, reaching out and generating increased interest among researchers and students to contribute to new or better solutions to various needs in society, creates opportunities for Gunilla Lundmark and the staff of UU Invest to hone their work – and be the first investors to join the companies on their way to the market.

“Yes, I am very pleased with the good work of UU Innovation, and I applaud the efforts and great skills of the staff,” says Gunilla.

Investing in interesting new companies

2021 has also been a successful year for UU Invest, with a highly positive result. Strike Pharma, Disruptive Pharma, MM18 Medical and Rarity Bioscience are four new companies that have been added to the portfolio.

“As we work in an ‘evergreen structure’, where returns on investments made are the basis for future investments, this provides a good starting point for new investments in the companies that are in the pipeline. We stand firm and secure. In 2021, we made some 20 investments and doubled our investment capital. We also stepped up our outreach to other investors for both co-investments and later-stage investments. During the year, we also started work to tell and communicate more about our activities, our companies and, in particular, the researchers and students who have set up companies to take their research further. The hope is that this will inspire others to do the same. So the call to action is – follow us and be inspired by the advice and experience of others,” says Gunilla.

Increased interest in portfolio companies from investors

Gunilla believes that 2021 has also been a year of increased interest in investing in early-stage companies and increased access to venture capital from both business angels and larger investors – something that has resulted in greater interest in investing in UU Invest’s portfolio companies. This is encouraging, according to Gunilla, who sees it as a stamp of quality that strengthens the attractiveness of the University’s holding company and increases interest in investing in the companies. During the year, UU Invest and the foundation Beijerstiftelsen also intensified their collaboration to increase the conditions for funding and commercialising new research ideas, starting in 2022.

The project company – an opportunity to grow ideas into companies

Although the roles of UU Innovation and UU Invest are clear, they collaborate on some joint projects in UU Invest’s project company Uppsala University Projekt AB. This is where the companies with the promising ideas that are not quite ready for incorporation are found.

The collaboration is a great opportunity for both UU Innovation and UU Invest to follow and support the ideas. The projects are given time to refine their business idea and, through experienced consultants, test their offering, analyse the target group and market and, not least, build a team with the right skills. When the time is ripe, the projects can then transition into a company in which UU Invest may invest. Two examples of ideas that have matured are Strike Pharma and Rolling Optics, two companies in which UU Invest has invested.

Strong desire to increase efforts in 2022

For 2022, Malin and Gunilla’s plans are in place and work is underway. A strong desire to increase efforts to reach more researchers and students and to use the assistance they each offer to encourage more people to take their research further to society runs like a common thread through both UU Innovation and UU Invest’s work. The fact that one does not exclude the other is another message both stand behind. Taking an idea further or taking research further to society does not mean a person’s time as researcher is over. On the contrary. It creates new and interesting opportunities.

In more concrete terms, this is what Malin and Gunilla want to see happen in 2022:

Malin: I am full of anticipation for this year, and hope to be able to say that we have really found a way to effectively reach out to new researchers and students with our offering. We have developed a clearer outflow strategy for the projects we support, which I hope we can see positive results from already in 2022. This includes working more clearly with sustainability issues, the importance of having a team around your project, and fine-tuning the communication of the project to generate more interest in it. With this in mind, it is my firm hope that our work will lead to UU Invest being able to make more new investments than usual during the year.

Gunilla: In 2022, I want us to double the number of new investments. I want to increase the number of projects we get involved in, and I want our activities to expand so that the investments we have already made increase our returns – so that we can invest in more companies. I also hope that we reach out to more students than we do today, and that we invest in more student-founded companies during the year.

Read more about UU Innovation and UU Invest

Aktuellt

Visa:

Jacinto Sá, Professor vid Institutionen för kemi – Ångström

More pleasant indoor climate with new energy-efficient technology

Development is progressing rapidly at the new company Duck Technologies. If everything goes according to plan, the hope is that the company’s first product will be ready for the market within two years. What remains is to scale up and package a new opportunity to save energy by reducing heat intake through, among other things, windows in buildings and cars.

me

International research collaboration brings hope for glioblastoma treatment

Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer. The startup is preparing clinical trials to create a drug aimed at extending patients’ lives.

vinnarna av venturechallenge2024

The duo behind SoundSim360 – Winners of VentureChallenge 2024

SoundSim360, developed by Professor Ken Mattsson and Dr. Gustav Eriksson, is an advanced sound simulation tool for precise sound level predictions that handles complex acoustics, including low-frequency sounds for wind turbines, arenas, and home theater systems.

Collaboration graphic visual. Teamwork graphics.

From Research to Business – Collaboration between UU Innovation and UU Invest shorten your time to market

UU Invest hosts your project so that you can establish necessary agreements with collaborative partners, hire key personnel to investigate or develop the concept, and also assist ‘hands on’ in negotiations and strategic work.

Ida-Maria Sintorn portrait

SimSearch – New powerful tool in the work with biological microscope images

Ida-Maria Sintorn, along with her colleagues in the SimSearch project, is developing new technology for image processing of microscopic images. The focus is to make it easier, faster, and safer for researchers to extract relevant information from large amounts of data while retaining control over their own data.

CEO of HyEnGen Oscar Verho

HyEnGen – Pioneering Research for Sustainable Energy Production

Oscar Verho and his research network are focused on creating more efficient ways to produce fuels from water. The path involves advanced interdisciplinary development and a sustainable, efficient electrode with the potential to make green hydrogen production more cost-effective.

Matteo, en av Paperhives grundare.

AI accelerates evidence-based clinical decisions

PapersHive is one of UU Invest’s 55 portfolio companies. With an AI-based search technology, the company collects information from all medical databases in one place. This saves both time and money for pharmaceutical companies, CROs and medical technology companies.

Graphic footage with text that describes that venturechallenge 2023 is now closed.

Applications for VentureChallenge 2023 are now closed

Applications for VentureChallenge 2023 are now closed. A new call for applications will open again in the first quarter of 2024.

Linus Bosaeus, VD för Rarity Bioscience

Precisionsdiagnostik i fokus för Rarity Bioscience

Ulf Landegren och hans forskningsgrupp ligger bakom banbrytande forskning som lett till nya innovationer som framgångsrikt förvaltats och utvecklats i en rad olika bolag. Rarity Bioscience med vd Linus Bosaeus är ett av de senaste i raden.